Business
Nxera Pharma Proposes Changes to its Board of Directors
Mr. Takeo Morooka nominated for appointment as new External DirectorMs. Miwa Seki and Mr. Noriaki Nagai to retire from the Board of Directors Tokyo, Japan and Cambridge, UK, 13 February 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that its Board of Directors approved the change of Directors as stated below. The nomination of candidates for External Directors is based on the resolution of the Nomination Committee. The appointments are expected to be ratified
About this update from Nxera Pharma Co., Ltd.
[{"type":"image","alt":"Nxera Pharma","displaySize":"","headline":null,"caption":"Nxera Pharma","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":101,"url":"https://media.zenfs.com/en/globenewswire.com/3c5c5d1f11d2ca9444665ce7b9191638"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/MMtO8FGLy1ULu25TBGkF3w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/3c5c5d1f11d2ca9444665ce7b9191638","width":300,"height":101}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Mr. Takeo Morooka nominated for appointment as new External Director","length":68,"tagName":"p"}]},{"val":[{"type":"text","content":"Ms. Miwa Seki and Mr. Noriaki Nagai to retire from the Board of Directors","length":73,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":141,"olType":false},{"type":"text","content":"Tokyo, Japan and Cambridge, UK, 13 February 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that its Board of Directors approved the change of Directors as stated below. The nomination of candidates for External Directors is based on the resolution of the Nomination Committee. The appointments are expected to be ratified officially, subject to the passing of resolutions to be made at the 36th Ordinary General Meeting of Shareholders, scheduled to be held on 25 March 2026.","length":511,"tagName":"p"},{"type":"text","content":"Chris Cargill, President & CEO of Nxera Pharma, said: “We welcome the appointment of Mr. Morooka as a candidate for External Director of Nxera Pharma. He brings extensive experience in his field, and we expect that, with his deep expertise in regulatory affairs and pharmaceutical policy, he will provide practical and constructive guidance in advancing our medium- to long-term growth strategy and enhancing corporate value, as we further develop Nxera into a leading player in the biopharmaceutical industry. At the same time, we would like to express our sincere gratitude to the outgoing Directors for their many years of dedicated service and significant contributions to the Company’s growth and development.”","length":719,"tagName":"p"},{"type":"text","content":"1. Change of Directors(1) Content of the Change","length":90,"tagName":"p"},{"type":"table","headerItems":[],"...